Spero Therapeutics, Inc.SPRONASDAQ
Loading
Operating Margin Over TimeExpanding
Percentile Rank70
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Percentile
P70
Within normal range
vs 2Y Ago
-6.3x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM-130.89%+14.4%
2024-152.91%-838.7%
202320.70%+123.8%
2022-86.86%+97.0%
2021-2865.50%-237.9%
2020-847.94%-143.4%
2019-348.36%+67.7%
2018-1079.32%+48.8%
2017-2108.64%+78.7%
2016-9916.72%-